(VIANEWS) – American Electric Power Company (AEP), SSR Mining (SSRM), FS Bancorp (FSBW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. American Electric Power Company (AEP)
146521% sales growth and 8.28% return on equity
American Electric Power Company, Inc., an electric public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States. It operates through Vertically Integrated Utilities, Transmission and Distribution Utilities, AEP Transmission Holdco, and Generation & Marketing segments. The company generates electricity using coal and lignite, natural gas, renewable, nuclear, hydro, solar, wind, and other energy sources. It also supplies and markets electric power at wholesale to other electric utility companies, rural electric cooperatives, municipalities, and other market participants. The company was incorporated in 1906 and is headquartered in Columbus, Ohio.
Earnings Per Share
As for profitability, American Electric Power Company has a trailing twelve months EPS of $3.85.
PE Ratio
American Electric Power Company has a trailing twelve months price to earnings ratio of 21.6. Meaning, the purchaser of the share is investing $21.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.28%.
2. SSR Mining (SSRM)
158.9% sales growth and 3.97% return on equity
SSR Mining Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and operation of precious metal resource properties in Turkey and the Americas. The company explores for gold, silver, copper, lead, and zinc deposits. Its projects include the Çöpler Gold mine located in Erzincan, Turkey; the Marigold mine located in Humboldt County, Nevada, the United States; the Seabee Gold Operation located in Saskatchewan, Canada; and the Puna Operations in Jujuy, Argentina. The company was formerly known as Silver Standard Resources Inc. and changed its name to SSR Mining Inc. in August 2017. SSR Mining Inc. was incorporated in 1946 and is based in Denver, Colorado.
Earnings Per Share
As for profitability, SSR Mining has a trailing twelve months EPS of $0.7.
PE Ratio
SSR Mining has a trailing twelve months price to earnings ratio of 21.39. Meaning, the purchaser of the share is investing $21.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.97%.
Yearly Top and Bottom Value
SSR Mining’s stock is valued at $14.97 at 20:22 EST, way under its 52-week high of $21.24 and way higher than its 52-week low of $12.78.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11.5%, now sitting on 1.11B for the twelve trailing months.
Sales Growth
SSR Mining’s sales growth is negative 2.2% for the ongoing quarter and 158.9% for the next.
3. FS Bancorp (FSBW)
21.6% sales growth and 12.97% return on equity
FS Bancorp, Inc. operates as a bank holding company for 1st Security Bank of Washington that provides banking and financial services to local families, local and regional businesses, and industry niches. The company operates in two segments, Commercial and Consumer Banking; and Home Lending. It offers various deposit instruments, including checking accounts, money market deposit accounts, savings accounts, and certificates of deposit. The company provides one-to-four-family residential first mortgages, second mortgage/home equity loan products, non-mortgage commercial business loans, commercial real estate loans, and construction and development loans, as well as consumer loans, which primarily include personal lines of credit, credit cards, automobile, direct home improvement, loans on deposit, and recreational loans. As of December 31, 2021, it operated 21 full bank service branches and 10 home loan production offices in suburban communities in the greater Puget Sound area, including Snohomish, King, Pierce, Jefferson, Kitsap, Clallam, Grays Harbor, Thurston, and Lewis counties; and one loan production office in the market area of the Tri-Cities. The company was founded in 1936 and is headquartered in Mountlake Terrace, Washington.
Earnings Per Share
As for profitability, FS Bancorp has a trailing twelve months EPS of $3.91.
PE Ratio
FS Bancorp has a trailing twelve months price to earnings ratio of 7.8. Meaning, the purchaser of the share is investing $7.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.97%.
Moving Average
FS Bancorp’s worth is higher than its 50-day moving average of $29.16 and under its 200-day moving average of $31.19.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.6%, now sitting on 122.39M for the twelve trailing months.
4. Haemonetics Corporation (HAE)
16.3% sales growth and 14.72% return on equity
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Haemonetics Corporation has a trailing twelve months EPS of $2.25.
PE Ratio
Haemonetics Corporation has a trailing twelve months price to earnings ratio of 39.18. Meaning, the purchaser of the share is investing $39.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.72%.
Volume
Today’s last reported volume for Haemonetics Corporation is 59675 which is 80.11% below its average volume of 300174.
Yearly Top and Bottom Value
Haemonetics Corporation’s stock is valued at $88.16 at 20:22 EST, below its 52-week high of $91.39 and way higher than its 52-week low of $58.23.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 25.9% and 7.2%, respectively.
Moving Average
Haemonetics Corporation’s value is above its 50-day moving average of $83.85 and above its 200-day moving average of $80.69.
5. Chesapeake Utilities Corporation (CPK)
12.3% sales growth and 10.72% return on equity
Chesapeake Utilities Corporation operates as an energy delivery company. The Regulated Energy segment engages in the natural gas distribution operations in central and southern Delaware, Maryland's eastern shore, and Florida; regulated natural gas transmission in the Delmarva Peninsula and Florida; and regulated electric distribution in northeast and northwest Florida. The Unregulated Energy segment engages in the propane operations in the Mid-Atlantic region and Florida; unregulated natural gas transmission/supply operation in central and eastern Ohio; generation of electricity and steam; and provision of compressed natural gas, liquefied natural gas, and renewable natural gas transportation and pipeline solutions primarily to utilities and pipelines in the eastern United States. This segment also provides other unregulated energy services, such as energy-related merchandise sales; heating, ventilation, and air conditioning services; and plumbing and electrical services. The company was founded in 1859 and is headquartered in Dover, Delaware.
Earnings Per Share
As for profitability, Chesapeake Utilities Corporation has a trailing twelve months EPS of $5.15.
PE Ratio
Chesapeake Utilities Corporation has a trailing twelve months price to earnings ratio of 24.82. Meaning, the purchaser of the share is investing $24.82 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.72%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 2.36 and the estimated forward annual dividend yield is 1.87%.
Yearly Top and Bottom Value
Chesapeake Utilities Corporation’s stock is valued at $127.82 at 20:22 EST, below its 52-week high of $138.49 and way above its 52-week low of $105.79.
Sales Growth
Chesapeake Utilities Corporation’s sales growth is 13.5% for the ongoing quarter and 12.3% for the next.
6. Apollo Medical Holdings (AMEH)
9.3% sales growth and 9.51% return on equity
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare management company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Earnings Per Share
As for profitability, Apollo Medical Holdings has a trailing twelve months EPS of $1.09.
PE Ratio
Apollo Medical Holdings has a trailing twelve months price to earnings ratio of 28.32. Meaning, the purchaser of the share is investing $28.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.51%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Apollo Medical Holdings’s EBITDA is 1.22.
7. Hexcel Corporation (HXL)
7% sales growth and 9.73% return on equity
Hexcel Corporation, together with its subsidiaries, develops, manufactures, and markets structural materials for use in commercial aerospace, space and defense, and industrial markets. It operates through two segments, Composite Materials and Engineered Products. The Composite Materials segment manufactures and markets carbon fibers, fabrics and specialty reinforcements, prepregs and other fiber-reinforced matrix materials, structural adhesives, honeycomb, molding compounds, tooling materials, polyurethane systems, and laminates that are used in military and commercial aircraft, wind turbine blades, recreational products, and other industrial applications, as well as in automotive, marine, and trains. The Engineered Products segment manufactures and markets aircraft structures and finished aircraft components, including wing to body fairings, wing panels, flight deck panels, door liners, rotorcraft blades, spars, and tip caps; and aircraft structural sub-components and semi-finished components used in rotorcraft blades, engine nacelles, and aircraft surfaces, such as flaps, wings, elevators, and fairings. The company sells its products directly through its managers, product managers, and sales personnel, as well as through independent distributors and manufacturer representatives in the Americas, Europe, the Asia Pacific, India, and Africa. Hexcel Corporation was founded in 1946 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, Hexcel Corporation has a trailing twelve months EPS of $1.78.
PE Ratio
Hexcel Corporation has a trailing twelve months price to earnings ratio of 41.39. Meaning, the purchaser of the share is investing $41.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.73%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 3, 2023, the estimated forward annual dividend rate is 0.5 and the estimated forward annual dividend yield is 0.69%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 45.5% and 39.4%, respectively.
Moving Average
Hexcel Corporation’s worth is above its 50-day moving average of $70.32 and way above its 200-day moving average of $63.63.
